MicroRNA-378 promotes mesenchymal stem cell survival and vascularization under hypoxic-Ischemic conditions in vitro

Stem Cell Research and Therapy

Volumn 5, Issue 6, 2014, Pages

  Xing, Yue ^a   Hou, Jingying ^a   Guo, Tianzhu ^a   Zheng, Shaoxin ^a,b   Zhou, Changqing ^a   Huang, Hui ^a,b   Chen, Yuyang ^a   Sun, Kan ^a   Zhong, Tingting ^a   Wang, Jingfeng ^a,b   Li, Honghao ^a   Wang, Tong ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Province Key Laboratory of Arrhythmia and Electrophysiology   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 378; PLATELET DERIVED GROWTH FACTOR B; PROTEIN BAX; PROTEIN BCL 2; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN; BAX PROTEIN, RAT; MIRN378 MICRORNA, RAT; TUMOR SUPPRESSOR PROTEIN; TUSC2 PROTEIN, RAT;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; BONE MARROW; CELL CULTURE; CELL PROLIFERATION; CELL SURVIVAL; COCULTURE; CONTROLLED STUDY; DRUG EFFICACY; HYPOXIA; IN VITRO STUDY; ISCHEMIC HEART DISEASE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REOXYGENATION; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULARIZATION; ANIMAL; CELL HYPOXIA; CYTOLOGY; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL HYPOXIA; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MESENCHYMAL STROMAL CELLS; MICRORNAS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTO-ONCOGENE PROTEINS C-BCL-2; RATS; RATS, SPRAGUE-DAWLEY; TUMOR NECROSIS FACTOR-ALPHA; TUMOR SUPPRESSOR PROTEINS;

EID: 84927708379     PISSN: None     EISSN: 17576512     Source Type: Journal    
DOI: 10.1186/scrt520     Document Type: Article

References (57)

1. Hou J, Wang L, Jiang J, Zhou C, Guo T, Zheng S, Wang T: Cardiac stem cells and their roles in myocardial infarction. Stem Cell Rev 2013, 9:326-338.
2. Chavakis E, Koyanagi M, Dimmeler S: Enhancing the outcome of cell therapy for cardiac repair progress from bench to bedside and back. Circulation 2010, 121:325-335.
3. Wang T, Tang W, Sun S, Wan Z, Xu T, Huang Z, Weil MH: Mesenchymal stem cells improve outcomes of cardiopulmonary resuscitation in myocardial infarcted rats. J Mol Cell Cardiol 2009, 46:378-384.
4. Hare JM, Fishman JE, Gerstenblith G, Velazquez DLD, Zambrano JP, Suncion VY, Tracy M, Ghersin E, Johnston PV, Brinker JA: Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: The POSEIDON Randomized Trial Mesenchymal Stem Cells and Ischemic Cardiomyopathy. JAMA 2012, 308:2369-2379.
5. Mathiasen AB, Jørgensen E, Qayyum AA, Haack-Sørensen M, Ekblond A, Kastrup J: Rationale and design of the first randomized, double-blind, placebo-controlled trial of intramyocardial injection of autologous bone-marrow derived Mesenchymal Stromal Cells in chronic ischemic Heart Failure (MSC-HF Trial). Am Heart J 2012, 164:285-291.
6. Wen Z, Zheng S, Zhou C, Wang J, Wang T: Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction. J Cell Mol Med 2011, 15:1032-1043.
7. Williams AR, Hare JM: Mesenchymal stem cells biology, pathophysiology, translational findings, and therapeutic implications for cardiac disease. Circ Res 2011, 109:923-940.
8. Wang T, Sun S, Wan Z, Weil MH, Tang W: Effects of bone marrow mesenchymal stem cells in a rat model of myocardial infarction. Resuscitation 2012, 83:1391-1396.
9. Figeac F, Lesault PF, Coz O, Damy T, Souktani R, Trébeau C, Schmitt A, Ribot J, Mounier R, Guguin A: Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells. Stem Cells 2014, 32:216-230.
10. Lee RH, Oh JY, Choi H, Bazhanov N: Therapeutic factors secreted by mesenchymal stromal cells and tissue repair. J Cell Biochem 2011, 112:3073-3078.
11. Trachtenberg B, Velazquez DL, Williams AR, McNiece I, Fishman J, Nguyen K, Rouy D, Altman P, Schwarz R, Mendizabal A: Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Heart Failure Secondary to Myocardial Infarction (TAC-HFT) trial: a randomized, double-blind, placebo-controlled study of safety and efficacy. Am Heart J 2011, 161:487-493.
12. Hare JM, Traverse JH, Henry TD, Dib N, Strumpf RK, Schulman SP, Gerstenblith G, DeMaria AN, Denktas AE, Gammon RS: A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J Am Coll Cardiol 2009, 54:2277-2286.
13. Copland IB, Lord-Dufour S, Cuerquis J, Coutu DL, Annabi B, Wang E, Galipeau J: Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition. Stem Cells 2009, 27:467-477.
14. McGinley LM, McMahon J, Stocca A, Duffy A, Flynn A, O'Toole D, O'Brien T: Mesenchymal stem cell survival in the infarcted heart is enhanced by lentivirus vector-mediated heat shock protein 27 expression. Hum Gene Ther 2013, 24:840-851.
15. Zhu W, Chen J, Cong X, Hu S, Chen X: Hypoxia and serum deprivation-induced apoptosis in mesenchymal stem cells. Stem Cells 2006, 24:416-425.
16. Hou M, Liu J, Liu F, Liu K, Yu B: C1q tumor necrosis factor-related protein-3 protects mesenchymal stem cells against hypoxia-and serum deprivation-induced apoptosis through the phosphoinositide 3-kinase/Akt pathway. Int J Mol Med 2014, 33:97-104.
17. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233.
18. Nie Y, Han B-M, Liu X-B, Yang J-J, Wang F, Cong X-F, Chen X: Identification of MicroRNAs involved in hypoxia-and serum deprivation-induced apoptosis in mesenchymal stem cells. Int J Biol Sci 2011, 7:762-768.
19. Huang F, Zhu X, Hu X-Q, Fang Z-F, Tang L, Lu X-L, Zhou S-H: Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival. Int J Mol Med 2013, 31:484-492.
20. Wen Z, Zheng S, Zhou C, Yuan W, Wang J, Wang T: Bone marrow mesenchymal stem cells for post?myocardial infarction cardiac repair: micrornas as novel regulators. J Cell Mol Med 2012, 16:657-671.
21. Lee DY, Deng Z, Wang C-H, Yang BB: MicroRNA-378 promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression. Proc Nat Acad Sci U S A 2007, 104:20350-20355.
22. Kim SW, Kim HW, Huang W, Okada M, Welge JA, Wang Y, Ashraf M: Cardiac stem cells with electrical stimulation improve ischaemic heart function through regulation of connective tissue growth factor and miR-378. Cardiovasc Res 2013, 100:241-251.
23. Fang J, Song X-W, Tian J, Chen H-Y, Li D-F, Wang J-F, Ren A-J, Yuan W-J, Lin L: Overexpression of microRNA-378 attenuates ischemia-induced apoptosis by inhibiting caspase-3 expression in cardiac myocytes. Apoptosis 2012, 17:410-423.
24. Knezevic I, Patel A, Sundaresan NR, Gupta MP, Solaro RJ, Nagalingam RS, Gupta M: A novel cardiomyocyte-enriched MicroRNA, miR-378, targets insulin-like growth factor 1 receptor implications in postnatal cardiac remodeling and cell survival. J Biol Chem 2012, 287:12913-12926.
25. Nagalingam RS, Sundaresan NR, Gupta MP, Geenen DL, Solaro RJ, Gupta M: A cardiac-enriched microRNA, miR-378, blocks cardiac hypertrophy by targeting Ras signaling. J Biol Chem 2013, 288: 11216-11232.
26. Prasad SVN, Duan Z-H, Gupta MK, Surampudi VSK, Volinia S, Calin GA, Liu CG, Kotwal A, Moravec CS, Starling RC: Unique microRNA profile in end-stage heart failure indicates alterations in specific cardiovascular signaling networks. J Biol Chem 2009, 284:27487-27499.
27. Wang T, Tang W, Sun S, Ristagno G, Huang Z, Weil MH: Intravenous infusion of bone marrow mesenchymal stem cells improves myocardial function in a rat model of myocardial ischemia. Crit Care Med 2007, 35:2587-2593.
28. Brill A, Dashevsky O, Rivo J, Gozal Y, Varon D: Platelet-derived microparticles induce angiogenesis and stimulate post-ischemic revascularization. Cardiovasc Res 2005, 67:30-38.
29. Wang S, Qu X, Zhao RC: Clinical applications of mesenchymal stem cells. J Hematol Oncol 2012, 5:19.
30. Wang J, Li Z, Zhang Y, Liu X, Chen L, Chen Y: CX43 change in LPS preconditioning against apoptosis of mesenchymal stem cells induced by hypoxia and serum deprivation is associated with ERK signaling pathway. Mol Cell Biochem 2013, 380:267-275.
31. Zhang Q, Yang Y-J, Wang H, Dong Q-T, Wang T-J, Qian H-Y, Xu H: Autophagy activation: a novel mechanism of atorvastatin to protect mesenchymal stem cells from hypoxia and serum deprivation via AMP-activated protein kinase/mammalian target of rapamycin pathway. Stem Cells Dev 2012, 21:1321-1332.
32. Huang F, Li M-L, Fang Z-F, Hu X-Q, Liu Q-M, Liu Z-J, Tang L, Zhao Y-S, Zhou S-H: Overexpression of MicroRNA-1 improves the efficacy of mesenchymal stem cell transplantation after myocardial infarction. Cardiology 2013, 125:18-30.
33. Ouyang YB, Giffard RG: microRNAs affect BCL-2 family proteins in the setting of cerebral ischemia. Neurochem Int 2014, 77:2-8.
34. Ji L, Roth JA: Tumor suppressor FUS1 signaling pathway. J Thorac Oncol 2008, 3:327.
35. Mao J, Lv Z, Zhuang Y: MicroRNA-23a is involved in tumor necrosis factor-α induced apoptosis in mesenchymal stem cells and myocardial infarction. Exp Mol Pathol 2014, 97:23-30.
36. Peng C-F, Han Y-L, Yan C-H: Overexpression of cellular repressor of E1A-stimulated genes inhibits TNF-α-induced apoptosis via NF-κB in mesenchymal stem cells. Biochem Biophys Res Commun 2011, 406:601-607.
37. Poynter JA, Herrmann JL, Manukyan MC, Wang Y, Abarbanell AM, Weil BR, Brewster BD, Meldrum DR: Intracoronary mesenchymal stem cells promote postischemic myocardial functional recovery, decrease inflammation, and reduce apoptosis via a signal transducer and activator of transcription 3 mechanism. J Am Coll Surg 2011, 213:253-260.
38. Collino F, Bruno S, Deregibus MC, Tetta C, Camussi G: MicroRNAs and mesenchymal stem cells. Vitam Horm 2011, 87:291-320.
39. L-l Z, J-j L, Liu F, W-h L, Wang Y-s, Zhu B, Yu B: MiR-499 induces cardiac differentiation of rat mesenchymal stem cells through wnt/β-catenin signaling pathway. Biochem Biophys Res Commun 2012, 420:875-881.
40. Bonauer A, Boon RA, Dimmeler S: Vascular micrornas. Curr Drug Targets 2010, 11:943-949.
41. Wang S, Olson EN: AngiomiRs - key regulators of angiogenesis. Curr Opin Gene Dev 2009, 19:205-211.
42. Yang J, Zhou W, Zheng W, Ma Y, Lin L, Tang T, Liu J, Yu J, Zhou X, Hu J: Effects of myocardial transplantation of marrow mesenchymal stem cells transfected with vascular endothelial growth factor for the improvement of heart function and angiogenesis after myocardial infarction. Cardiology 2006, 107:17-29.
43. Kim SH, Moon H-H, Kim HA, Hwang K-C, Lee M, Choi D: Hypoxia-inducible vascular endothelial growth factor-engineered mesenchymal stem cells prevent myocardial ischemic injury. Mol Ther 2011, 19:741-750.
44. Penna C, Perrelli MG, Karam JP, Angotti C, Muscari C, Montero-Menei CN, Pagliaro P: Pharmacologically active microcarriers influence VEGF-A effects on mesenchymal stem cell survival. J Cell Mol Med 2013, 17:192-204.
45. Skrzypek K, Tertil M, Golda S, Ciesla M, Weglarczyk K, Collet G, Guichard A, Kozakowska M, Boczkowski J, Was H: Interplay between heme oxygenase-1 and miR-378 affects non-small cell lung carcinoma growth, vascularization, and metastasis. Antioxid Redox Signal 2013, 19:644-660.
46. Guiducci S, Manetti M, Romano E, Mazzanti B, Ceccarelli C, Dal Pozzo S, Milia AF, Bellando-Randone S, Fiori G, Conforti ML: Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann Rheum Dis 2011, 70:2011-2021.
47. Ball S, Worthington J, Canfield A, Merry C, Kielty C: Mesenchymal stromal cells: inhibiting PDGF receptors or depleting fibronectin induces mesodermal progenitors with endothelial potential. Stem Cells 2014, 32:694-705.
48. Ho IA, Toh HC, Ng WH, Teo YL, Guo CM, Hui KM, Lam PY: Human bone marrow?derived mesenchymal stem cells suppress human glioma growth through inhibition of angiogenesis. Stem Cells 2013, 31: 146-155.
49. Zhang J, Chintalgattu V, Shih T, Ai D, Xia Y, Khakoo AY: MicroRNA-9 is an activation-induced regulator of PDGFR-beta expression in cardiomyocytes. J Mol Cell Cardiol 2011, 51: 337-346.
50. Böttner M, Krieglstein K, Unsicker K: The transforming growth factor-βs. J Neurochem 2000, 75:2227-2240.
51. Zhao L, Hantash BM: TGF-β1 regulates differentiation of bone marrow mesenchymal stem cells. Vitam Horm 2011, 87:127-141.
52. Kurpinski K, Chu J, Wang D, Li S: Proteomic profiling of mesenchymal stem cell responses to mechanical strain and TGF-beta1. Cell Mol Bioeng 2009, 2:606-614.
53. Zhen G, Wen C, Jia X, Li Y, Crane JL, Mears SC, Askin FB, Frassica FJ, Chang W, Yao J: Inhibition of TGF-[beta] signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat Med 2013, 19: 704-712.
54. Kato M: TGF-β-induced signaling circuit loops mediated by microRNAs as new therapeutic targets for renal fibrosis? Kidney Int 2013, 84:1067-1069.
55. Kitamura K, Seike M, Okano T, Matsuda K, Miyanaga A, Mizutani H, Noro R, Minegishi Y, Kubota K, Gemma A: MiR-134/487b/655 cluster regulates TGF-β-induced epithelial -mesenchymal transition and drug resistance to gefitinib by targeting MAGI2 in lung adenocarcinoma cells. Mol Cancer Ther 2014, 13:444-453.
56. Sun X, He Y, Ma T-T, Huang C, Zhang L, Li J: Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation. Mol Cell Biochem 2014, 388:11-23.
57. Ghosh D, Lili L, McGrail DJ, Matyunina LV, McDonald JF, Dawson MR: Integral role of platelet-derived growth factor in mediating transforming growth factor-β1-dependent mesenchymal stem cell stiffening. Stem Cells Dev 2014, 23:245-261.